Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DMK Pharmaceuticals (DMKPQ)
OTHER OTC:DMKPQ
Holding DMKPQ?
Track your performance easily
DMKPQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.82
Previous Close$0.01
Volume581.00
Average Volume (3M)N/A
Market Cap
$10.00
Enterprise Value-$6.60M
Total Cash (Recent Filing)$6.66M
Total Debt (Recent Filing)$63.21K
Price to Earnings (P/E)―
Beta-32.60
Next Earnings
Nov 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-9.18
Shares Outstanding10,102,050
10 Day Avg. Volume1,609
30 Day Avg. VolumeN/A
Standard Deviation0.83
R-Squared0.00746
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.87
Enterprise Value/Gross Profit4.61
Enterprise Value/Ebitda0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DMKPQ FAQ
What was DMK Pharmaceuticals’s price range in the past 12 months?
DMK Pharmaceuticals lowest stock price was <$0.01 and its highest was $0.82 in the past 12 months.
What is DMK Pharmaceuticals’s market cap?
Currently, no data Available
When is DMK Pharmaceuticals’s upcoming earnings report date?
DMK Pharmaceuticals’s upcoming earnings report date is Nov 12, 2024 which is 41 days ago.
How were DMK Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is DMK Pharmaceuticals overvalued?
According to Wall Street analysts DMK Pharmaceuticals’s price is currently Overvalued.
Does DMK Pharmaceuticals pay dividends?
DMK Pharmaceuticals does not currently pay dividends.
What is DMK Pharmaceuticals’s EPS estimate?
DMK Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DMK Pharmaceuticals have?
DMK Pharmaceuticals has 10,102,050 shares outstanding.
What happened to DMK Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of DMK Pharmaceuticals?
Currently, no hedge funds are holding shares in DMKPQ
---
Company Description
DMK Pharmaceuticals
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
---
DMKPQ Earnings Call
Q1 2023
0:00 / 0:00
---
DMKPQ Stock 12 Month Forecast
Average Price Target
―---